U.S. Court of Appeals for the Federal Circuit, 2023

Ucb, Inc. v. Annora Pharma Private Limited

Ucb, Inc. v. Annora Pharma Private Limited
U.S. Court of Appeals for the Federal Circuit · Decided November 21, 2023
Ucb, Inc. v. Annora Pharma Private Limited

Opinion

Case: 24-1056 Document: 12 Page: 1 Filed: 11/21/2023

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

UCB, INC., UCB BIOPHARMA SRL,

Plaintiffs-Appellees v.

ANNORA PHARMA PRIVATE LIMITED,

APOTEX INC., APOTEX CORP.,

Defendants

MSN PHARMACEUTICALS, INC., MSN

LABORATORIES PRIVATE LTD.,

Defendants-Appellants ______________________

2024-1056 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:20-cv-00987-CFC-JLH, 1:20- cv-01343-CFC, Chief Judge Colm F. Connolly. ______________________

ORDER

The parties having so agreed, it is ordered that: (1) The proceeding is DISMISSED under Fed. R. App. P. 42 (b).

Case: 24-1056 Document: 12 Page: 2 Filed: 11/21/2023

2 UCB, INC. V. ANNORA PHARMA PRIVATE LIMITED

(2) Each side shall bear their own costs.

FOR THE COURT November 21, 2023

Date /s/ Jarrett B. Perlow Jarrett B. Perlow Clerk of Court

ISSUED AS A MANDATE: November 21, 2023

Case-law data current through September 30, 2026. Source: CourtListener bulk data.